Triptorelin (GnRH) 2mg
Triptorelin is a gonadotropin-releasing hormone analogue that has been used in the clinical setting to treat advanced prostate cancer as part of a multi-faceted approach to androgen deprivation therapy. Similar to luteinizing hormone-releasing hormone, triptorelin is a potent inhibitor of testosterone and estrogen synthesis when given in long-term, continuous dosing. In the UK, triptorelin is used to suppress testosterone and estrogen synthesis in transgender people. The peptide has also found application in the treatment of hormone-receptor-positive breast cancer in premenopausal women.
All products listed and provided through UK Peptides are intended for research purposes only. We do not promote the personal use of these products.
Products provided by UK Peptides are not intended for use in food products or as any type of drug. Our products are not intended to treat, prevent, mitigate or cure any disease or medical condition and are for research purposes only.